Previous Close | 519.96 |
Open | 519.96 |
Bid | 518.57 x 800 |
Ask | 519.44 x 800 |
Day's Range | 517.96 - 521.12 |
52 Week Range | 412.00 - 521.18 |
Volume | |
Avg. Volume | 1,023,793 |
Market Cap | 120.648B |
Beta (5Y Monthly) | 0.78 |
PE Ratio (TTM) | 20.58 |
EPS (TTM) | 25.20 |
Earnings Date | Apr 17, 2024 - Apr 22, 2024 |
Forward Dividend & Yield | 6.52 (1.26%) |
Ex-Dividend Date | Mar 07, 2024 |
1y Target Est | 578.63 |
Subscribe to Yahoo Finance Plus to view Fair Value for ELV
In this piece, we will take a look at the stocks in which half of Leon Cooperman’s latest investment portfolio is invested. If you want to skip our overview of the billionaire investor and dividend investing, then you can take a look at 29 Percent of Billionaire Cooperman’s Portfolio is Invested in These 5 Dividend […]
The first major U.S. health insurers have agreed to start paying for the popular anti-obesity drug Wegovy for certain people on Medicare with heart-related conditions.
In the latest trading session, Elevance Health (ELV) closed at $513.85, marking a -0.16% move from the previous day.